Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126892041 | 12689204 | 1 | I | 20160818 | 20160826 | 20160826 | EXP | CA-AMGEN-CANSP2016109243 | AMGEN | 73.00 | YR | E | F | Y | 0.00000 | 20160826 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126892041 | 12689204 | 1 | PS | ENBREL | ETANERCEPT | 1 | Subcutaneous | 50 MG, UNK | U | 103795 | 50 | MG | UNKNOWN FORMULATION | ||||||
| 126892041 | 12689204 | 2 | SS | HUMIRA | ADALIMUMAB | 1 | Subcutaneous | 40 MG, UNK | 0 | 40 | MG | ||||||||
| 126892041 | 12689204 | 3 | SS | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Unknown | 200 MG, UNK | 0 | 200 | MG | ||||||||
| 126892041 | 12689204 | 4 | SS | HYDROXYCHLOROQUINE | HYDROXYCHLOROQUINE | 1 | Unknown | 200 MG, UNK | 0 | 200 | MG | ||||||||
| 126892041 | 12689204 | 5 | SS | INFLIXIMAB | INFLIXIMAB | 1 | Unknown | UNK | 0 | ||||||||||
| 126892041 | 12689204 | 6 | SS | METHOTREXATE. | METHOTREXATE | 1 | Unknown | 20 MG, UNK | 0 | 20 | MG | ||||||||
| 126892041 | 12689204 | 7 | SS | ORENCIA | ABATACEPT | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 126892041 | 12689204 | 8 | SS | PREDNISONE. | PREDNISONE | 1 | Unknown | 9 MG, UNK | 0 | 9 | MG | ||||||||
| 126892041 | 12689204 | 9 | SS | RITUXAN | RITUXIMAB | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 126892041 | 12689204 | 10 | SS | XELJANZ | TOFACITINIB CITRATE | 1 | Oral | 5 MG, UNK | 0 | 5 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126892041 | 12689204 | 1 | Rheumatoid arthritis |
| 126892041 | 12689204 | 2 | Rheumatoid arthritis |
| 126892041 | 12689204 | 3 | Rheumatoid arthritis |
| 126892041 | 12689204 | 5 | Rheumatoid arthritis |
| 126892041 | 12689204 | 6 | Rheumatoid arthritis |
| 126892041 | 12689204 | 7 | Rheumatoid arthritis |
| 126892041 | 12689204 | 8 | Rheumatoid arthritis |
| 126892041 | 12689204 | 9 | Product used for unknown indication |
| 126892041 | 12689204 | 10 | Rheumatoid arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126892041 | 12689204 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126892041 | 12689204 | Abdominal pain upper | |
| 126892041 | 12689204 | Alopecia | |
| 126892041 | 12689204 | Anxiety | |
| 126892041 | 12689204 | Asthenia | |
| 126892041 | 12689204 | Depression | |
| 126892041 | 12689204 | Drug dependence | |
| 126892041 | 12689204 | Drug ineffective | |
| 126892041 | 12689204 | Fall | |
| 126892041 | 12689204 | Fatigue | |
| 126892041 | 12689204 | Headache | |
| 126892041 | 12689204 | Inflammation | |
| 126892041 | 12689204 | Joint injury | |
| 126892041 | 12689204 | Malaise | |
| 126892041 | 12689204 | Pain | |
| 126892041 | 12689204 | Red blood cell sedimentation rate increased | |
| 126892041 | 12689204 | Synovitis |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |